Wednesday, October 4, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Biology

Research identifies pathway connecting some ARV drugs with liver disease

January 31, 2019
in Biology
0
Share on FacebookShare on Twitter

As a raft of new treatments for HIV infection have come on the market in the past 20 years, AIDS patients got access to drugs that allowed them to live longer.

“These drugs are miracles,” said Dr. Richard N. Greenberg, an infectious disease specialist at the University of Kentucky. “Before the advent of anti-retroviral drugs, HIV infection was a death sentence. Now, taken properly, the life span of a person with an HIV infection is practically normal.”

However, many of these anti-retroviral (ARV) drugs — most notably a class of drugs called Non- Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) — have been associated with liver disease. In fact, liver disease has emerged as the most common non-AIDS related cause of death in HIV-infected patients, accounting for almost one in every five deaths.

But new research published in the Journal of Hepatology could be another step towards the development of treatments that help HIV patients without elevating their risk for cardiovascular or liver disease. A group led by Changcheng Zhou, Ph.D. at the University of Kentucky has established a pathway that seems to be responsible for deleterious side effects of the widely-prescribed NNRTI drug efavirenz.

Like all organisms, humans are exposed to chemical compounds that would be toxic were it not for metabolic mechanisms that moderate their effects. A receptor known as pregnane X receptor (PXR) plays an integral role in this process. The underlying mechanisms responsible for one adverse effect of ARV drugs — fat accumulation in the liver — had not yet been identified. Zhou et al were curious: did ARV drugs interact with PXR in a way that increased lipid levels?

Using both naïve mice and a new liver-specific PXR deletion mouse model, they established that efavirenz “turned on” PXR target genes both in vivo and in vitro, thereby stimulating fatty acid uptake and cholesterol synthesis in a dose-dependent manner. A translational mouse model (expressing human PXR instead of mouse PXR) was used to confirm those findings.

“These findings provide new understanding of the mechanism by which ARV therapy induces dyslipidemia and identify potential targets for treatment to mitigate increased cardiovascular and liver disease risk conferred by efavirenz,” said Zhou.

Greenberg, who collaborated with Zhou on this study, views this research as both guidance for clinicians and a doorway for further research.

“Translational medicine begins with a mechanism,” Greenberg said. “Now that we’ve found a pathway that leads to fat accumulation in the liver, we can look for useful applications, including possible treatments that mitigate the side effects of PXR agonists like efavirenz.”

“In the interim, clinicians should take heed of this research and be vigilant on behalf of their patients who have been prescribed PXR agonists.”

###

Media Contact
Laura Wright
laurawright@uky.edu
859-257-5307
http://dx.doi.org/10.1016/j.jhep.2018.12.038

Tags: AIDS/HIVCholesterolGenesLiverMedicine/HealthMetabolism/Metabolic Diseases
Share25Tweet16Share4ShareSendShare
  • AI-designed robot

    Instant evolution: AI designs new robot from scratch in seconds

    68 shares
    Share 27 Tweet 17
  • Lasers deflected using air

    65 shares
    Share 26 Tweet 16
  • New $81million NIH grant will help U.S. answer urgent need for better dementia care

    65 shares
    Share 26 Tweet 16
  • African BioGenome Project (AfricaBP) Open Institute for Genomics and Bioinformatics Workshop 2023

    93 shares
    Share 37 Tweet 23
  • Pumped for frigid weather: study pinpoints cold adaptations in nervous system of Antarctic octopus

    68 shares
    Share 27 Tweet 17
  • Men with metastatic prostate cancer live longer thanks to new drugs

    67 shares
    Share 27 Tweet 17
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Null results research now published by major behavioral medicine journal

Groundbreaking mathematical proof: new insights into typhoon dynamics unveiled

Weather researchers explore deep convective clouds in coastal cities

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 208 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In